Tyra Biosciences, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023
Profitability
EBT Margin 40,526.09%138,389.47%110,650.00%177,266.67%
EBIT Margin 40,421.74%138,357.89%117,854.00%204,987.18%
EBITDA Margin 40,421.74%138,357.89%110,650.00%176,289.74%
Operating Margin 40,421.74%138,357.89%117,854.00%204,987.18%
Net Margin 40,526.09%138,389.47%110,650.00%177,266.67%
FCF Margin 35,108.70%128,452.63%101,688.00%130,535.90%
Leverage & Solvency
Interest Coverage Ratio -404.22-0.00M-0.00M-0.00M
Times Interest Earned -404.22-0.00M-0.00M-0.00M
Valuation
Enterprise Value 580.61M320.70M596.36M
Market Capitalization 580.61M320.70M596.36M
Return Ratios
Return on Sales 405.26%